Elevance raised its 2026 adjusted EPS guidance to at least $27 after second-quarter outperformance.
Medicare Advantage is tracking to at least a 2% operating margin in 2026 after portfolio repositioning.
CareBridge home-based care is being expanded into new markets, with mid-teens medical savings potential.
Elevance plans to expand its risk-based oncology solution into Medicaid in the second half of 2026.
Elevance now expects to end 2026 with at least 1 million individual ACA members.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Elevance Health Inc. and 4,900+ companies.